Al-Zubi Mohammad Talal, Demour Saddam Al, Al-Rawashdah Samer Fathi, Carbone Antonio, Pastore Antonio Luigi, Abuhamad Mohannad, Abuorouq Saleh, Al-Azab Rami, Bani-Hani Morad, Al-Qudah Mohammad, Elayan Basel
Department of Surgery, Division of Urology, School of Medicine, Yarmouk University, Irbid, 21110, Jordan.
Department of Special Surgery, Division of Urology, School of Medicine, The University of Jordan, Amman, 11972, Jordan.
Future Sci OA. 2023 Jan 23;8(9):FSO823. doi: 10.2144/fsoa-2022-0045. eCollection 2022 Oct.
Bladder cancer is the second most common urological malignancy after prostate cancer. Increase in the post-void residual (PVR) volume may result in an increase in the risk of cancer recurrence.
Patient demographic data, tumor stage and grade, PVR volume and 2 years follow-up data for recurrence were obtained and evaluated.
One-hundred-and-nineteen patients were subdivided into three groups according to PVR urine volume. The increase of PVR volume was related to short recurrence-free survival (RFS) especially for patients with PVR volume of 60 ml or more.
Low PVR volume in patients with non-muscle invasive bladder cancer may play a role in reducing cancer recurrence. However further research is needed in this field.
膀胱癌是继前列腺癌之后第二常见的泌尿系统恶性肿瘤。排尿后残余尿量(PVR)增加可能会导致癌症复发风险上升。
获取并评估患者的人口统计学数据、肿瘤分期和分级、PVR尿量以及2年的复发随访数据。
119例患者根据PVR尿量分为三组。PVR尿量增加与无复发生存期(RFS)缩短相关,尤其是对于PVR尿量为60毫升或更多的患者。
非肌层浸润性膀胱癌患者的低PVR尿量可能在降低癌症复发方面发挥作用。然而,该领域仍需进一步研究。